C- myc gene chromatin of estrogen receptor positive and negative breast cancer cells
Expression of the c- myc protooncogene is estrogen regulated in estrogen receptor (ER) positive, hormone-dependent human breast cancer cells, but it is constitutively active in ER negative, hormone-independent breast cancer cells. To determine whether these differences are reflected in c- myc chroma...
Saved in:
Published in | Molecular and cellular endocrinology Vol. 91; no. 1; pp. 83 - 89 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Shannon
Elsevier Ireland Ltd
01.02.1993
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Expression of the c-
myc protooncogene is estrogen regulated in estrogen receptor (ER) positive, hormone-dependent human breast cancer cells, but it is constitutively active in ER negative, hormone-independent breast cancer cells. To determine whether these differences are reflected in c-
myc chromatin, DNase I hypersensitive sites (DHS) were mapped. Six DHS were detected in all cell lines studied, with DHS 3
2 being more prominent than DHS 3
1. The accessibility of DHS 2 was markedly greater in ER negative cells than in ER positive cells, and this relative accessibility remained unchanged when cells were grown in estrogen free medium. DHS 2, 3
1 and 3
2 map near the P0, P1 and P2 promoters, respectively. An analysis of promoter usage demonstrated that P2 was the preferred promoter. Thus, the differences in the accessibility of DHS 2 in c-
myc chromatin of ER positive and negative cells likely reflects alterations in DNA-protein interactions in this region. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0303-7207 1872-8057 |
DOI: | 10.1016/0303-7207(93)90258-L |